This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

MLOZ Selects Sapiens IDIT Software Suite For Mutual, Mandatory And Complementary Health Insurances

ANTWERP, Belgium, September 24, 2013 /PRNewswire/ --

Sapiens International Corporation, (NASDAQ and TASE: SPNS), a global provider of innovative software solutions for the financial services industry, announced today that MLOZ, the National Federation of Independent Health Insurance Funds, offering services to more than 18% of the Belgian population, has selected Sapiens IDIT Software Suite, to manage its health insurance portfolio, in a multimillion dollar deal.

     (Logo: http://photos.prnewswire.com/prnh/20120508/531104 )

As part of the organization's overall strategy to facilitate the health insurance services in Belgium, MLOZ will be implementing the Sapiens IDIT Software Suite to modernize its technology environment to support the provision and management of health insurances, including: mutual insurances ("SMA"), mandatory health insurances, and complementary health insurances.

Anticipated benefits from this multi-year IDIT Software Suite implementation include:

  • Support for thousands of concurrent online users;
  • A holistic view of the client;
  • Ability to leverage data for improved customer relations;
  • Improved time to market for new products;
  • Best practices in product design and business process optimization;
  • Reduced overall IT costs.

Commenting on the selection of Sapiens IDIT, MLOZ's Managing Director, Xavier Brenez said, "We have selected Sapiens due to the rich business functionality of its software and the professionalism and quality of their personnel. We see a tremendous amount of value in Sapiens' domain expertise and understanding of our unique business needs, as well as the cultural alignment between the organizations, which bodes well for the relationship going forwards."

Roni Al-Dor, President and CEO of Sapiens commented, "We are proud to have MLOZ as our customer, and appreciate their recognition of our software and the value of our dedicated and skilled staff. MLOZ joins a growing and impressive portfolio of customers that have chosen to work with Sapiens, and we look forward to helping MLOZ derive the highest possible value from this solution."

Al-Dor continued, "We see a lot of opportunities for Sapiens in the health insurance market and feel the MLOZ win validates our strong position and will help us to further expand our health market footprint."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs